Immunogenicity of tetanus-diphtheria toxoids (Td) among Ukrainian adults: implications for diphtheria control in the Newly Independent States of the Former Soviet Union.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 10657214)

Published in J Infect Dis on February 01, 2000

Authors

R W Sutter1, I R Hardy, I A Kozlova, L M Tchoudnaia, T G Gluskevich, V Marievsky, A Deforest, M Wharton

Author Affiliations

1: Child Vaccine Preventable Disease Branch, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. rws4@cdc.gov

Articles citing this

Immunogenicity and safety of diphtheria-tetanus vaccine in adults. J Korean Med Sci (2010) 0.80

Articles by these authors

Intussusception among infants given an oral rotavirus vaccine. N Engl J Med (2001) 5.33

Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis (1999) 3.48

Cost-effectiveness of a routine varicella vaccination program for US children. JAMA (1994) 3.27

Molecular epidemiology of diphtheria in Russia, 1985-1994. J Infect Dis (1996) 2.12

Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics (1996) 1.79

Application of PCR for detection of toxigenic Corynebacterium diphtheriae strains isolated during the Russian diphtheria epidemic, 1990 through 1994. J Clin Microbiol (1995) 1.76

Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis (2000) 1.76

Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis (1999) 1.61

Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis (1998) 1.57

Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics (1995) 1.52

Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus. Clin Immunol Immunopathol (1986) 1.44

Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis (2000) 1.41

Septic arthritis due to Micrococcus luteus. J Rheumatol (1986) 1.39

Are we ready for diphtheria? A report from the Diphtheria Diagnostic Workshop, Atlanta, 11 and 12 July 1994. J Infect Dis (1995) 1.32

The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics (1995) 1.28

Small animals are not susceptible to human immunodeficiency virus infection. J Gen Virol (1987) 1.24

Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis (1995) 1.21

Evaluation of a method for detecting aberrations in public health surveillance data. Am J Epidemiol (1993) 1.21

Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol (1994) 1.20

Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy. Pediatrics (1990) 1.18

Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies. J Infect Dis (2000) 1.07

Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis (1991) 1.04

Tetanus surveillance--United States, 1995-1997. MMWR CDC Surveill Summ (1998) 1.03

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics (1997) 1.03

Diphtheria toxoid vaccine effectiveness: A case-control study in Russia. J Infect Dis (2000) 1.00

Serologic evidence of subclinical pertussis in immunized children. Pediatr Infect Dis J (1990) 0.98

Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J Pediatr (1993) 0.96

The effect of breast-feeding on the antibody response of infants to trivalent oral poliovirus vaccine. J Pediatr (1973) 0.96

Pertussis outbreak in an elementary school with high vaccination coverage. Pediatr Infect Dis J (2001) 0.96

Respiratory diphtheria in the United States, 1980 through 1995. Am J Public Health (1998) 0.95

Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States. Clin Infect Dis (2000) 0.94

Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin Infect Dis (1996) 0.93

Ukraine, 1992: first assessment of diphtheria vaccine effectiveness during the recent resurgence of diphtheria in the Former Soviet Union. J Infect Dis (2000) 0.92

Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system. Pediatrics (2001) 0.92

Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994. J Infect Dis (1997) 0.92

Novel dihydrofolate reductases isolated from epidemic strains of trimethoprim/sulfamethoxazole-resistant Shigella sonnei. J Infect Dis (1990) 0.89

Tetanus surveillance--United States, 1991-1994. MMWR CDC Surveill Summ (1997) 0.89

Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussis. Infect Immun (1994) 0.88

Diphtheria surveillance and control in the Former Soviet Union and the Newly Independent States. J Infect Dis (2000) 0.87

Myocardial rhabdomyosarcoma in multiple neurofibromatosis. Neurology (1981) 0.87

Response to measles-mumps-rubella vaccine in children on dialysis. Pediatr Nephrol (1992) 0.83

Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants. Vaccine (2001) 0.83

Giant cell arteritis and polymyalgia rheumatica in a conjugal pair. Arthritis Rheum (1981) 0.82

Evaluation of a single dose of diphtheria toxoid among adults in the Republic of Georgia, 1995: immunogenicity and adverse reactions. J Infect Dis (2000) 0.82

Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines. Pediatrics (1995) 0.82

Epidemic diphtheria in the Newly Independent States of the Former Soviet Union: implications for diphtheria control in the United States. J Infect Dis (2000) 0.80

Immunization response varies with intensity of acute lymphoblastic leukemia therapy. Am J Dis Child (1991) 0.80

Underreporting of pertussis deaths in the United States: need for improved surveillance. Pediatrics (1998) 0.79

How many doses of diphtheria toxoid are required for protection in adults? Results of a case-control study among 40- to 49-year-old adults in the Russian Federation. J Infect Dis (2000) 0.79

Ukraine's diphtheria campaign. Lancet (1996) 0.79

Measles control in Kinshasa, Zaire improved with high coverage and use of medium titre Edmonston Zagreb vaccine at age 6 months. Int J Epidemiol (1994) 0.78

Experimental anaerobic liver abscess: observations on treatment. Liver (1986) 0.78

Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant (1996) 0.78

The 1993 pertussis epidemic in Cincinnati. N Engl J Med (1994) 0.78

Intravenous immunoglobulin prophylaxis of cytomegalovirus infection in pediatric renal transplant recipients. Am J Nephrol (1997) 0.77

Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine. Biologicals (1998) 0.77

Response of human immunodeficiency virus-infected adults to measles-rubella vaccination. J Acquir Immune Defic Syndr (1993) 0.77

Correlation between levels of autoantibodies to nerve growth factor and the clinical features of schizophrenia in children. Neurosci Behav Physiol (2000) 0.76

Vaccine-associated paralytic poliomyelitis in the United States: no evidence of elevated risk after simultaneous intramuscular injections of vaccine. Pediatr Infect Dis J (1995) 0.76

[Typology of disordered eating behaviour (anorexia nervosa with bulimia and vomitomanic disturbances) in children and adolescents]. Zh Nevrol Psikhiatr Im S S Korsakova (2004) 0.76

[Analysis of EEG structural synchrony in adolescents suffering from schizophrenic disorders]. Fiziol Cheloveka (2005) 0.76

Dose-response to acellular pertussis vaccine and comparison with whole cell pertussis vaccine at 15-24 months and 4-6 years of age. Acellular Pertussis Vaccine Study Team. Vaccine (1992) 0.76

[Dynamics of the recovery of disturbed functions in patients with stroke after carotid endarterectomy]. Zh Nevrol Psikhiatr Im S S Korsakova (2009) 0.76

Measles immunization in HCWs. Infect Control Hosp Epidemiol (1994) 0.75

[An elevation in the level of autoantibodies to nerve-growth factor in the blood serum of schizophrenic children]. Zh Nevrol Psikhiatr Im S S Korsakova (1997) 0.75

Sir Benjamin Brodie, Bt. (1783-1862). Ann R Coll Surg Engl (1983) 0.75

Immunity to diphtheria in a sample of the Canadian adult population. Can J Infect Dis (1998) 0.75

Response to the varicella vaccine in children with nephrotic syndrome. J Pediatr (1997) 0.75

The measles-mumps-rubella vaccination program in Finland. N Engl J Med (1995) 0.75

Stable seroprevalence of HIV-1 in antenatal women in rural Bas-Zaïre, 1988-1993. AIDS (1994) 0.75

[Effects of histone on the intracellular development of vaccinia virus]. Vopr Virusol (1967) 0.75

[Induction of the "stripping enzyme" in different viruses of the smallpox-vaccinia group]. Dokl Akad Nauk SSSR (1966) 0.75

[Effect of some inhibitors on the formation of the factor of nucleocapside deproteinization in vaccinia virus]. Dokl Akad Nauk SSSR (1966) 0.75

Impact of treatment guidelines on use of ribavirin. Am J Dis Child (1990) 0.75

Immunogenicity of high-titer Edmonston-Zagreb measles vaccine in human immunodeficiency virus-infected children in Kinshasa, Zaire. J Infect Dis (1993) 0.75

[Suppression of synthesis of smallpox vaccine virus by histone]. Dokl Akad Nauk SSSR (1965) 0.75

Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines. Pediatrics (1995) 0.75

On the mechanism of action of interferon on the early stage of vaccinia virus reproduction. Acta Virol (1967) 0.75

[Experience in the use of the new artificial lung ventilation apparatus "Avenir-221P" for treatment of children]. Med Tekh (2006) 0.75

Influence of sex on ventricular remodeling in collegiate athletes. J Sports Med Phys Fitness (2012) 0.75

Pertussis. Bull World Health Organ (1998) 0.75

[Determination of the synthesis of poliovirus antigens with the use of gamma-globulin labled with I-131]. Vopr Virusol (1966) 0.75

Epidemiology of diphtheria in South Dakota. S D J Med (2000) 0.75

[On the origin of the factor causing deproteinization of the nucleocapsid of vaccinia virus]. Vopr Virusol (1967) 0.75

Sir Gilbert Blane Bt (1749-1834). Ann R Coll Surg Engl (1984) 0.75

Letter: Failure of measles vaccination. J Pediatr (1973) 0.75

Synthesis of DNA and protein in cells infected with vaccinia virus. Nature (1966) 0.75

[The mechanism of action of interferon on smallpox virus multiplication and cellular metabolism]. Vopr Virusol (1969) 0.75

Tetanus immune status of adult patients in an urban family practice. J Fam Pract (1986) 0.75

The determination of Miconazole and its related production impurities together with basic solution stability studies using a sub 2 μm chromatographic column. J Chromatogr Sci (2012) 0.75

The changing face of hospital. Nurs Mirror Midwives J (1975) 0.75

[Synthesis of proteins and nucleic components of vaccinia virus]. Vopr Virusol (1969) 0.75

Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions. J Infect Dis (2000) 0.75